NAT1 and cancer: In particular, (HUMAN)NAT1 is up-regulated in several cancer types, thereby leading to cancer cell growth and resistance to chemotherapy, and has emerged as a viable candidate for drug development, which should lead to small molecule inhibitors for preclinical and clinical evaluation28.